Mistral Pharma Inc. Announces Approval of Instillagel(TM) by Health Canada

MONTREAL, QUEBEC -- (MARKET WIRE) -- May 08, 2007 -- Mistral Pharma Inc. (TSX VENTURE: MIP) ("Mistral") announces today that Health Canada has approved CuraMedica (Canada) Inc.'s ("CuraMedica") Instillagel® for sale and marketing in Canada. CuraMedica was acquired by Mistral Pharma on May 4th, 2007.
MORE ON THIS TOPIC